Schisandrin A ameliorates obesity and MAFLD through bile acid context-dependent modulation of intestinal FXR signaling
Authors:
- Xu WangXWXu Wang
- Yaping JiangYJYaping Jiang
- Lianshun FengLFLianshun Feng
- Yixuan LuoYLYixuan Luo
- Jiali ZhangJZJiali Zhang
- Xunjiang WangXWXunjiang Wang
- Yanfei WangYWYanfei Wang
- Yujie MaYMYujie Ma
- Mengdie HuaMHMengdie Hua
- Lihua JinLJLihua Jin
- Weian YuanWYWeian Yuan
- Zhengtao WangZWZhengtao Wang
- 18 August 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 161
Abstract
No abstract availableFunding Information
- Shanghai Municipal Health Commission (2024PT007)
- National Major Science and Technology Projects of China (2025ZD01906000)
- National Major Science and Technology Projects of China (2025ZD01906004)
- National Science and Technology Major Project
- National Natural Science Foundation of China (82505115)
- National Natural Science Foundation of China (U24A20775)
- National Natural Science Foundation of China (82274165)
- National Natural Science Foundation of China (82122074)
- National Natural Science Foundation of China (U24A20792)
This publication has 34 references indexed in Scilit:
- Lactobacillus reuteri‐mediated dietary xylooligosaccharides enhance jejunal cell survival via suppression of oxygen‐dependent apoptotic processes in a pig modeliMeta, 2025
- Exploring the tissue distribution propensity of active alkaloids in normal and stomach heat syndrome rats following oral administration of Zuojin Pill based on pharmacokinetics and mass spectrometry imagingJournal of Ethnopharmacology, 2025
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- Evidence of anti-inflammatory activity of Schizandrin A in animal models of acute inflammationNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR AntagonistCell Metabolism, 2013
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α PathwayCell Metabolism, 2011
- Targeting murine small bowel and colon through selective superior mesenteric artery injectionMicrosurgery, 2010
- The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptorHepatology, 2008
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008
- Identification of a nuclear receptor that is activated by farnesol metabolitesCell, 1995